1. Home
  2. FN vs DXCM Comparison

FN vs DXCM Comparison

Compare FN & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fabrinet

FN

Fabrinet

HOLD

Current Price

$721.79

Market Cap

24.3B

Sector

Utilities

ML Signal

HOLD

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$61.50

Market Cap

26.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FN
DXCM
Founded
1999
1999
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3B
26.5B
IPO Year
2007
2005

Fundamental Metrics

Financial Performance
Metric
FN
DXCM
Price
$721.79
$61.50
Analyst Decision
Buy
Strong Buy
Analyst Count
8
21
Target Price
$513.43
$85.33
AVG Volume (30 Days)
740.0K
4.5M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
13.21
47.18
EPS
9.22
0.51
Revenue
$3,419,327,000.00
N/A
Revenue This Year
$36.87
$14.46
Revenue Next Year
$17.91
$12.31
P/E Ratio
$79.95
$113.50
Revenue Growth
18.60
N/A
52 Week Low
$222.67
$54.11
52 Week High
$740.73
$89.07

Technical Indicators

Market Signals
Indicator
FN
DXCM
Relative Strength Index (RSI) 58.50 50.42
Support Level $429.50 $56.72
Resistance Level $734.79 $65.87
Average True Range (ATR) 46.86 2.33
MACD 1.28 0.16
Stochastic Oscillator 83.18 73.65

Price Performance

Historical Comparison
FN
DXCM

About FN Fabrinet

Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: